Benjamin F. Edwards & Company Inc. Boosts Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Benjamin F. Edwards & Company Inc. grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.7% during the second quarter, HoldingsChannel reports. The institutional investor owned 2,405 shares of the company’s stock after buying an additional 171 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in GE HealthCare Technologies were worth $187,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. 9258 Wealth Management LLC grew its position in GE HealthCare Technologies by 5.7% in the 4th quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock valued at $253,000 after acquiring an additional 176 shares during the last quarter. Orion Portfolio Solutions LLC grew its holdings in shares of GE HealthCare Technologies by 128.6% in the fourth quarter. Orion Portfolio Solutions LLC now owns 22,614 shares of the company’s stock worth $1,749,000 after purchasing an additional 12,721 shares during the last quarter. Advisory Services Network LLC increased its stake in GE HealthCare Technologies by 15.2% in the 4th quarter. Advisory Services Network LLC now owns 12,549 shares of the company’s stock worth $970,000 after buying an additional 1,652 shares during the period. Hsbc Holdings PLC lifted its holdings in GE HealthCare Technologies by 21.1% during the 4th quarter. Hsbc Holdings PLC now owns 470,993 shares of the company’s stock valued at $36,408,000 after buying an additional 81,916 shares in the last quarter. Finally, United Services Automobile Association purchased a new stake in GE HealthCare Technologies in the 4th quarter valued at about $807,000. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of research reports. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Stifel Nicolaus started coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price objective on the stock. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company. Finally, UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $84.00 to $74.00 in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $93.92.

GE HealthCare Technologies Stock Down 0.6 %

Shares of GE HealthCare Technologies stock opened at $92.49 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. The company has a market cap of $42.22 billion, a P/E ratio of 27.04, a PEG ratio of 3.40 and a beta of 1.17. The firm’s 50 day moving average price is $84.90 and its 200-day moving average price is $83.32. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same period in the previous year, the company earned $0.92 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.